AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tagrica-M Tablet SR

Prescription Icon
Prescription Required

Marketer

Medirica Lifescience

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Tagrica-M Tablet SR

Combiflex-D Extended Release tablets contain a dual-action formula designed to manage elevated blood glucose in individuals with type 2 diabetes. This dual approach helps mitigate the risk of severe diabetic complications, including renal impairment and vision loss, and may also lower the probability of cardiovascular events like stroke or myocardial infarction. Combiflex-D ER may be used as a standalone therapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved when combined with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering current health status, glycemic control, and concomitant medications. Ingesting the medication with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Effective blood sugar regulation prevents future complications. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle factors are paramount. Commonly reported adverse events include nausea, vomiting, diarrhea, abdominal discomfort, and cephalgia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates awareness of its symptoms and management strategies. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic disorders, or significant alcohol consumption. Consult your doctor before use if pregnant or breastfeeding. Interaction with other medications is possible; disclose your complete medication list to ensure safety. Alcohol consumption should be minimized due to its potential to reduce blood glucose levels. Kidney function and blood glucose will be monitored by your physician throughout treatment.

Uses of Tagrica-M Tablet SR

Managing type 2 diabetes

Major Benefits of Tagrica-M Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Tagrica-M Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume this medication with food.

Common Side effects of Tagrica-M Tablet SR:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Tagrica-M Tablet SR:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Tagrica-M Tablet SR with a meal.

How Tagrica-M Tablet SR works:

Tagrica-M Extended-Release tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Tagrica-M Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tagrica-M Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Tagrica-M Tablet is likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Tagrica-M Tablet SR on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Tagrica-M Tablet SR, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Tagrica-M Tablet SR. Consult your physician. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Extended-release Tagrica-M tablets are contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is advised.

What if you forget to take Tagrica-M Tablet SR :

Should you forget a dose of Tagrica-M Tablet SR, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tagrica-M Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Tagrica-M Tablet SR

Tagrica-M Tablet SR is safe when taken as prescribed. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent issues to your doctor.
Tagrica-M Tablet SR typically doesn't cause low blood sugar (hypoglycemia) by itself. However, hypoglycemia can result from inadequate caloric intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Tagrica-M Tablet SR may cause nausea and vomiting. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Tagrica-M Tablet SR is contraindicated in patients with allergies to its components or excipients. It should also be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Tagrica-M Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect resulting from excess lactic acid in the bloodstream. This risk is higher in individuals with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Tagrica-M Tablet SR and seek immediate medical attention.
Yes, prolonged Tagrica-M Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency can cause anemia, nerve damage, and symptoms such as tingling or numbness in the extremities, weakness, urinary issues, cognitive changes, and balance problems (ataxia). If you experience any of these, consult your doctor; they may recommend vitamin B12 level monitoring and supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Tagrica-M Tablet SR
82
MRP 100
18% off